Skip to main content
. 2022 Feb 9;14(4):865. doi: 10.3390/cancers14040865

Table 1.

Univariate and multivariate Cox regression analysis of factors associated with overall survival and disease-free survival.

OS DFS
Univariate Multivariate Univariate Multivariate
Factor HR 95% CI p Value HR 95% CI p Value HR 95% CI p Value HR 95% CI p Value
Sex (male) 1.265 0.254–6.300 0.774 1.693 0.496–5.786 0.401
Age (years) 1.008 0.941–1.080 0.815 1.028 0.981–1.076 0.249
Liver cirrhosis
(yes vs. no)
3.747 0.450–31.170 0.222 0.747 0.280–1.994 0.560
Platelet (109/L) 1.002 0.993–1.011 0.627 1.007 1.001–1.012 0.015 1.015 1.005 1.024 0.002
Albumin (g/dL) 0.685 0.323–1.451 0.323 0.713 0.464–1.096 0.123
Total bilirubin (mg/dL) 1.502 1.083–2.083 0.015 1.380 0.993–1.917 0.055
Creatinine (mg/dL) 0.005 0.000–0.838 0.043 0.187 0.013–2.608 0.212
Serum AST
(U/L)
1.002 0.996–1.007 0.588 1.001 0.996–1.006 0.790
Serum ALT
(U/L)
1.007 1.000–1.013 0.035 1.005 1.000–1.010 0.057
Serum AFP (ng/mL) 1.000 1.000–1.000 <0.001 1.000 1.000 1.000 0.003 1.000 1.000–1.000 0.003
PIVKA II (mAU/mL) 1.000 1.000–1.000 0.003 1.000 1.000–1.000 0.002
MVI
(yes vs no)
0.002 0.000–7.853 0.144 13.464 4.210–43.055 <0.001 18.674 4.103 84.996 <0.001
mUICC
(III-IV vs. I-II)
17.153 2.092–140.608 0.008 7.691 2.889–20.473 <0.001
Tumor grade
(3–4 vs. 1–2)
0.045 0.000–32,060.773 0.653 22.504 0.004–144,372.189 0.486
SNRPB 5.672 1.051–30.609 0.044 4.550 1.496–13.836 0.008
CETN2 4.742 1.280–17.572 0.020 3.259 1.361–7.801 0.008
HMGA1 4.065 1.244–13.288 0.020 3.166 1.562–6.415 0.001 2.905 1.148 7.353 0.024
MPZL1 1.435 0.506–4.073 0.497 1.300 0.654–2.584 0.453
RACGAP1 6.631 2.375–18.519 <0.001 34.162 3.486 334.737 0.002 5.212 2.386–11.383 <0.001